News
The cause of death of the beloved 'WKRP in Cincinnati' actress, who died on Aug. 3, has finally been confirmed.
In a preclinical study, researchers found tamoxifen encourages uterine cell growth; the findings could change how some breast ...
Loni Anderson’s cause of death has been confirmed as a rare and aggressive form of uterine cancer that occurs in just 6 out ...
Actress Loni Anderson's cause of death revealed to be metastatic uterine leiomyosarcoma, according to a death certificate obtained by TMZ.
An international research team has identified a previously unknown mechanism by which the breast cancer drug tamoxifen can ...
20h
TipRanks on MSNAstraZeneca’s DESTINY-Endometrial01 Study: A New Horizon in Endometrial Cancer Treatment
The interventions being tested include Trastuzumab deruxtecan (T-DXd), an experimental therapy, combined with either Rilvegostomig or Pembrolizumab, both administered via intravenous infusion. These ...
20h
TipRanks on MSNBioNTech’s Promising Phase III Study in Recurrent Endometrial Cancer
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...
GLP-1 agonist users had a 17% lower cancer risk compared to non-users in a large retrospective study. The reductions achieved ...
IOVA's Q2'25 progress boosts confidence with Amtagvi growth & restructuring. Upcoming trial data & Canada launch may drive ...
GLP-1 receptor agonists may reduce cancer risk among people with obesity or overweight, according to retrospective study results.Adults who used GLP-1 medications exhibited a statistically significant ...
Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results